CIK 0001850119 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Century Therapeutics, Inc.
Sign in to watch- Ticker
- IPSC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 842040295
- Phone
- 215-981-4000
- Business address
- 25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,212
- in 5 filings
Net −$10,212. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 63 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-08 | Carr Douglas SVP Finance & Operations | Sale | −249 | $2.11 | $526 | 506,748 |
| 2026-06-05 | Pfeiffenberger Brent President and CEO | Shares withheld for taxes | −463 | $2.13 | $986 | 3,679,323 |
| 2026-05-15 | Pfeiffenberger Brent President and CEO | Shares withheld for taxes | −31,172 | $2.34 | $73K | 3,679,786 |
| 2026-05-04 | Carr Douglas SVP Finance & Operations | Sale | −264 | $2.34 | $618 | 506,997 |
| 2026-04-01 | Cowan Chad Chief Scientific Officer | Shares withheld for taxes | −1,365 | $2.19 | $3K | 1,175,680 |
| 2026-03-12 | Russotti Gregory See Remarks | Sale | −10,076 | $2.55 | $26K | 515,427 |
| 2026-03-12 | Carr Douglas SVP Finance & Operations | Sale | −7,043 | $2.55 | $18K | 507,261 |
| 2026-03-11 | Cowan Chad Chief Scientific Officer | Shares withheld for taxes | −1,431 | $2.73 | $4K | 1,177,045 |
| 2026-03-11 | Pfeiffenberger Brent President and CEO | Shares withheld for taxes | −55,397 | $2.73 | $151K | 3,710,958 |
| 2026-03-09 | Russotti Gregory See Remarks | Sale | −479 | $2.54 | $1K | 525,503 |
| 2026-03-09 | Carr Douglas SVP Finance & Operations | Sale | −247 | $2.54 | $626 | 514,304 |
| 2026-03-06 | Pfeiffenberger Brent President and CEO | Shares withheld for taxes | −463 | $2.56 | $1K | 3,766,355 |
| 2026-02-13 | Pfeiffenberger Brent President and CEO | Shares withheld for taxes | −31,172 | $1.75 | $55K | 3,766,818 |
| 2026-02-03 | Carr Douglas SVP Finance & Operations | Sale | −323 | $1.82 | $589 | 514,551 |
| 2026-02-02 | Cowan Chad Chief Scientific Officer | Grant or award | +135,000 | 1,178,476 | ||
| 2026-02-02 | Cowan Chad Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +265,000 | 265,000 | ||
| 2026-02-02 | Pfeiffenberger Brent President and CEO | Grant or award | +475,000 | 3,797,990 | ||
| 2026-02-02 | Pfeiffenberger Brent President and CEO | Grant or award · Stock Option (right to buy) | +945,000 | 945,000 | ||
| 2026-02-02 | Russotti Gregory See Remarks | Grant or award | +135,000 | 525,982 | ||
| 2026-02-02 | Russotti Gregory See Remarks | Grant or award · Stock Option (right to buy) | +265,000 | 265,000 |
Page 2 of 6 · 118 trades